Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone (Dara‐VRD): Striking response with no washout in a newly diagnosed multiple myeloma

Bibliographic Details
Main Authors:	Juan José Gil‐Fernández, Patricia García Ramírez, Marta Callejas Charavía
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Clinical Case Reports
Subjects:	daratumumab‐refractory myeloma first‐line therapy isatuximab post daratumumab newly diagnosed multiple myeloma
Online Access:	https://doi.org/10.1002/ccr3.8449

Internet

https://doi.org/10.1002/ccr3.8449